| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Nephrogenic Diabetes Insipidus
543
relevant articles (9 outcomes,
36 trials/studies)
found for this Disease
Description: A genetic or acquired polyuric disorder characterized by persistent hypotonic urine and HYPOKALEMIA. This condition is due to renal tubular insensitivity to VASOPRESSIN and failure to reduce urine volume. It may be the result of mutations of genes encoding VASOPRESSIN RECEPTORS or aquaporin-2 (AQUAPORINS); KIDNEY DISEASES; adverse drug effects; or complications from PREGNANCY.
Also Known As:Diabetes Insipidus, Nephrogenic; Acquired Nephrogenic Diabetes Insipidus; Congenital Nephrogenic Diabetes Insipidus; Diabetes Insipidus, Nephrogenic, Type I; Diabetes Insipidus, Nephrogenic, Type II; Nephrogenic Diabetes Insipidus, Type I; Nephrogenic Diabetes Insipidus, Type II
Relationship Network
Disease Context: Research Results
Related Diseases
| 1. | Depressive Disorder (Melancholia)
|
| 2. | Syndrome
|
| 3. | Cystic Fibrosis (Mucoviscidosis)
|
| 4. | Wilms Tumor (Wilm's Tumor)
|
| 5. | Hereditary Nephritis (Alport Syndrome)
|
Experts
| 1. | Deen, Peter M T: 10 articles (05/2008 - 02/2002) |
| 2. | Sasaki, Sei: 7 articles (09/2006 - 02/2002) |
| 3. | Bichet, Daniel G: 6 articles (05/2008 - 04/2002) |
| 4. | van Os, Carel H: 4 articles (05/2008 - 04/2002) |
| 5. | Uchida, Shinichi: 4 articles (09/2006 - 02/2002) |
| 6. | Verkman, A S: 4 articles (08/2006 - 04/2000) |
| 7. | Kamsteeg, Erik-Jan: 4 articles (04/2006 - 12/2003) |
| 8. | Konings, Irene B M: 4 articles (10/2005 - 09/2002) |
| 9. | Marr, Nannette: 4 articles (12/2004 - 02/2002) |
| 10. | Knoers, Nine V A M: 3 articles (05/2008 - 09/2002) |
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Nephrogenic Diabetes Insipidus:Therapies and Procedures
Best Treatments:
Research Summary Report
on Nephrogenic Diabetes Insipidus
Research Summary Report
on Nephrogenic Diabetes Insipidus
*WARNING* This specific disease subtype has a relatively small
number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a
more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
- Free Updates for 1 Year
- All 9 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Reference Details
- Sample PDF Report on Psoriasis >>
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License Details >>
| Price: | $490.00
access via web interface 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |